Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
4.0 Future therapeutic opportunities in neurodegenerative diseases Recent clinical and preclinical evidence has established the potential of incretin mimetics to target pathological features central to neurodegenerative disorders
Tirzepatide got approved and the research peptide market shrank, but it didn't disappear
As with any medication regimen, monitoring for side effects and adjusting dosages under medical supervision can help ensure safety and effectiveness, especially when dealing with the complexities of multiple medications
One study mentioned that endocrine therapies that are given as adjuvant treatments (such as aromatase inhibitors) can cause weight gain and obesity in breast cancer patients, and that GLP-1R agonists could reverse this effect
These are the price points most relevant to payers
